Our study found that the expression of IL-1β was significantly higher in ESCC tumor tissues than in paracancerous tissues, which aligns with the results obtained from the TIMER, GEPIA, and UALCAN database. This evidence concerns the gene IL1B and esophageal squamous cell carcinoma.